| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
8-K
| Quarterly results |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/07/2023 |
4
| McDermott Wendy (VP, Human Resources) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 6,000 shares
@ $1.84, valued at
$11k
|
|
| 08/04/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/04/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 07/31/2023 |
8-K
| Quarterly results |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/29/2023 |
4
| COATS LONNEL (CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 10,000 shares
@ $2.16, valued at
$21.6k
|
|
| 06/28/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 06/05/2023 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 27,775,050 shares
@ $2.6, valued at
$72.2M
|
|
| 06/02/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Underwriting Agreement, by and among Lexicon Pharmaceuticals, Inc. and Citigroup Global Markets Inc., Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein",
"Opinion of Vinson & Elkins L.L.P",
"Purchase Agreement, among Lexicon Pharmaceuticals, Inc. and Artal International S.C.A., Artal Group S.A., Artal International Management S.A., Invus Advisors, L.L.C., Invus Public Equities, L.P., Invus, L.P., Mr. Amaury Wittouck, Stichting Administratiekantoor Westend and Westend S.A",
"LEXICON ANNOUNCES PRICING OF $125 MILLION PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT" |
|
| 06/01/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 06/01/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 05/31/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 05/31/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 05/31/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/08/2023 |
8-K/A
| Submission of Matters to a Vote of Security Holders |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/28/2023 |
4
| Swain Judith L (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
4
| NIES ALAN S (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 04/28/2023 |
4
| LEFKOWITZ ROBERT J MD (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 04/28/2023 |
4
| DEBBANE RAYMOND (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 04/28/2023 |
4
| BARKER SAM L (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 04/28/2023 |
4
| Amouyal Philippe (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 03/17/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/17/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
|